Show simple item record

dc.contributor.authorKochhar, Rohit
dc.contributor.authorBrown, R K
dc.contributor.authorWong, C O
dc.contributor.authorDunnick, N R
dc.contributor.authorFrey, K A
dc.contributor.authorManoharan, Prakash
dc.date.accessioned2010-10-13T11:12:21Z
dc.date.available2010-10-13T11:12:21Z
dc.date.issued2010-08
dc.identifier.citationRole of FDG PET/CT in imaging of renal lesions. 2010, 54 (4):347-57 J Med Imaging Radiat Oncolen
dc.identifier.issn1754-9485
dc.identifier.pmid20718915
dc.identifier.doi10.1111/j.1754-9485.2010.02181.x
dc.identifier.urihttp://hdl.handle.net/10541/112880
dc.description.abstractFocal incidental renal lesions are commonly encountered on positron emission tomography (PET)/computed tomography (CT) imaging. The vast majority of these lesions are benign. However, the interpretation of renal lesions can be problematic if the imaging criteria of simple cysts are not met. Limited literature exists on the characterisation of renal masses with metabolic imaging. The purpose of this article is to focus on the imaging features of benign and malignant renal masses with PET/CT. The lesions discussed include renal cyst, angiomyolipoma, oncocytoma, renal cell carcinoma, renal metastases and other infiltrating neoplastic processes affecting the kidney. Both the anatomical and metabolic features which characterise these benign and malignant entities are described. We emphasise the importance of viewing the CT component to identify the typical morphological features and discuss how to best use hybrid imaging for management of renal lesions. Metabolic imaging has a promising role in the imaging of renal lesions and can help prevent unnecessary biopsies and ensure optimal management of suspicious lesions.
dc.language.isoenen
dc.subjectComputed Tomographyen
dc.subjectDiagnostic Imagingen
dc.subjectPositron Emission Tomographyen
dc.subjectRenal Lesionsen
dc.titleRole of FDG PET/CT in imaging of renal lesions.en
dc.typeArticleen
dc.contributor.departmentDepartment of Radiology, The Christie, NHS Foundation Trust, Manchester, UK.en
dc.identifier.journalJournal of Medical Imaging and Radiation Oncologyen
html.description.abstractFocal incidental renal lesions are commonly encountered on positron emission tomography (PET)/computed tomography (CT) imaging. The vast majority of these lesions are benign. However, the interpretation of renal lesions can be problematic if the imaging criteria of simple cysts are not met. Limited literature exists on the characterisation of renal masses with metabolic imaging. The purpose of this article is to focus on the imaging features of benign and malignant renal masses with PET/CT. The lesions discussed include renal cyst, angiomyolipoma, oncocytoma, renal cell carcinoma, renal metastases and other infiltrating neoplastic processes affecting the kidney. Both the anatomical and metabolic features which characterise these benign and malignant entities are described. We emphasise the importance of viewing the CT component to identify the typical morphological features and discuss how to best use hybrid imaging for management of renal lesions. Metabolic imaging has a promising role in the imaging of renal lesions and can help prevent unnecessary biopsies and ensure optimal management of suspicious lesions.


This item appears in the following Collection(s)

Show simple item record